Cargando…
Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer
BACKGROUND: Endometrial cancer (EC) is a common gynecologic malignancy and patients with advanced and recurrent EC have a poor prognosis. Although chemotherapy is administered for those patients, the efficacy of current chemotherapy is limited. Therefore, it is necessary to develop novel therapeutic...
Autores principales: | Nagase, Yoshikazu, Hiramatsu, Kosuke, Funauchi, Masashi, Shiomi, Mayu, Masuda, Tatsuo, Kakuda, Mamoru, Nakagawa, Satoshi, Miyoshi, Ai, Matsuzaki, Shinya, Kobayashi, Eiji, Kimura, Toshihiro, Serada, Satoshi, Ueda, Yutaka, Naka, Tetsuji, Kimura, Tadashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210735/ https://www.ncbi.nlm.nih.gov/pubmed/35729527 http://dx.doi.org/10.1186/s12885-022-09789-6 |
Ejemplares similares
-
Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer
por: Kanda, Mizuki, et al.
Publicado: (2022) -
CD70 antibody‐drug conjugate: A potential novel therapeutic agent for ovarian cancer
por: Shiomi, Mayu, et al.
Publicado: (2021) -
A single institution’s experience with minimally invasive surgery for ovarian cancer, and a systematic meta-analysis of the literature
por: Kamei, Yuji, et al.
Publicado: (2023) -
The ‘best friend effect’: a promising tool to encourage HPV vaccination in Japan
por: Yagi, Asami, et al.
Publicado: (2022) -
Disparities among Japanese municipalities in recommendations for routine and catch‐up HPV vaccinations
por: Watanabe, Yuko, et al.
Publicado: (2023)